Jeffrey Schulz has a diverse work experience spanning over a decade. Jeffrey started their career at Sabattis Adventure Camp in 2009 as a Program Director. From 2009 to 2014, they worked at PwC as an Assurance Associate and later as an Assurance Senior Associate. In 2014, they transitioned to Ironwood Pharmaceuticals, where they held the positions of Senior Manager, External Reporting & Controls and Senior Manager, Accounting. In 2017, Jeffrey joined Neon Therapeutics as an Assistant Controller. During their time at Cambridge College from 2015 to 2020, they served as a Senior Instructor in Financial Accounting. In 2020, they joined BioNTech SE as the Director of Finance and Accounting for their US division, and later as the Senior Director of Finance and Accounting. Currently, Jeffrey works at Decibel Therapeutics as the Senior Director, Controller, and is set to become the Vice President of Finance in 2023.
Jeffrey Schulz completed their Bachelor of Science (BS) degree in Accounting and Finance from Syracuse University, where they studied from 2005 to 2009. In 2012, they pursued further education at the University of Connecticut and obtained a Master of Science (M.S.) degree in Accounting in 2013. Additionally, they hold a Certification in Public Accounting (CPA), though no information regarding the institution or the year of obtaining the certification is provided.
April 1, 2023 - present
April, 2022